| 更新日期 | 產(chǎn)品編號 | 品牌 | 產(chǎn)品信息 | CAS號 | MDL號 | 規(guī)格與純度 | 包裝 | 價格 | 庫存信息 | 操作 |
|
2026/03/03
|
S6794
|
|
2-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-4-YL]OXY]ACETIC ACID
Thalidomide-O-COOH (Cereblon ligand 3)
|
1061605-21-7
|
|
|
5mg
|
570.13元
|
現(xiàn)貨
|
詳細
|
|
2026/03/03
|
S6794
|
|
2-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-4-YL]OXY]ACETIC ACID
Thalidomide-O-COOH (Cereblon ligand 3)
|
1061605-21-7
|
|
|
25mg
|
1570.54元
|
現(xiàn)貨
|
詳細
|
|
2025/12/22
|
XW02106160521704
|
|
2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚啉-4-基]氧基]乙酸
Thalidomide-O-COOH
|
1061605-21-7
|
|
|
5g
|
2622元
|
請詢貨期
|
詳細
|
|
2025/12/22
|
XW02106160521703
|
|
2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚啉-4-基]氧基]乙酸
Thalidomide-O-COOH
|
1061605-21-7
|
|
|
1g
|
622元
|
請詢貨期
|
詳細
|
|
2025/12/22
|
XW02106160521702
|
|
2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚啉-4-基]氧基]乙酸
Thalidomide-O-COOH
|
1061605-21-7
|
|
|
250mg
|
308元
|
請詢貨期
|
詳細
|
|
2025/12/22
|
XW02106160521701
|
|
2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚啉-4-基]氧基]乙酸
Thalidomide-O-COOH
|
1061605-21-7
|
|
|
100mg
|
233元
|
請詢貨期
|
詳細
|
|
2025/05/22
|
XW02106160521705
|
|
2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚啉-4-基]氧基]乙酸
Thalidomide-O-COOH
|
1061605-21-7
|
|
|
10g
|
5814元
|
請詢貨期
|
詳細
|